Skip to content

Bill Tracking

Bill Status Report Antonio Ciaccia
Tracking group: OPA Legislation Tracker

DEXTROMETHORPHAN SALES

To prohibit sales of dextromethorphan without a prescription to persons under age 18.
Text/Analysis
Committee Hearing in House Health (6/25/2019; CONTINUED)

VETERAN HEALTH CARE

To require certain entities to inform veterans about health care benefits available to all veterans.
Text/Analysis
Introduced and Referred in House (2/12/2019; Armed Services & Veterans Affairs)

DRUG INFORMATION

Regarding pharmacy benefit managers, pharmacists, and the disclosure to patients of drug price information.
Text/Analysis
Committee Hearing in House Health (6/4/2019; REPORTED (No testimony))

HB 166

(Enacted)
STATE BUDGET

To make operating appropriations for the biennium beginning July 1, 2019, and ending June 30, 2021, and to provide authorization and conditions for the operation of state programs.
Text/Analysis
Signed by the Governor (7/18/2019; Signed: July 18, 2019 with vetoes; Delivered to the governor July 17, 2019)

CLAIM INFORMATION

To require health plan insurers to release certain claim information to group plan policyholders.
Text/Analysis
Committee Hearing in House Insurance (5/7/2019; REPORTED-AMENDED)

DRUG INFORMATION

Regarding pharmacy benefit managers, pharmacists, and the disclosure to patients of drug price information.
Text/Analysis
Committee Hearing in Senate Insurance & Financial Institutions (4/3/2019; CONTINUED)

CONTROLLED SUBSTANCES

Regarding the disposal of controlled substances.
Text/Analysis
Committee Hearing in Senate Health, Human Services & Medicaid (4/10/2019; CONTINUED)

ALZHEIMER'S DISEASE

To establish the Alzheimer's Disease and Related Dementias Task Force.
Text/Analysis
Committee Hearing in House Aging & Long-Term Care (5/30/2019; REPORTED-AMENDED)

MEDICAID COPAYMENTS

Regarding Medicaid copayment requirements.
Text/Analysis
Committee Hearing in Senate Health, Human Services & Medicaid (2/19/2019; CONTINUED)

DRUG PRESCRIBING

Regarding non-opioid directives and non-opioid therapies.
Text/Analysis
Committee Hearing in Senate Health, Human Services & Medicaid (5/1/2019; CONTINUED)

SB 57

(Enacted)
HEMP

to establish conditions and requirements governing the regulation of hemp and hemp products, to amend the version of section 109.572 that is scheduled to take effect on September 20, 2019, and the versions of sections 3719.01, 3719.41, and 4729.01 of the Revised Code that are scheduled to take effect on March 22, 2020, to continue the provisions of this act on and after those dates, and to declare an emergency.
Text/Analysis
Signed by the Governor (7/30/2019; Signed: July 30, 2019)

NALOXONE DISPENSING

To require the State Board of Pharmacy to educate license holders about the law authorizing naloxone dispensing without a prescription.
Text/Analysis
Committee Hearing in Senate Health, Human Services & Medicaid (9/18/2019; CONTINUED)

Share

View